Israel Provoking Global Drug Patent Dispute, E.U. Warns
A 20-member forum of European economic attaches in Israel met at the European Union offices in Israel to discuss Israel's proposals for protecting pharmaceutical data exclusivity, according to local media reports.
The European Union, echoing similar sentiments by the U.S., is reported to be extremely dissatisfied with Israel's to limit protection of pharmaceutical information to marketing exclusivity...
To view the full article, register now.